TORONTO – Several U.S. and Canadian patients have recently undergone successful mitral valve surgery featuring a platform designed by Toronto-based Baylis Medical Inc. to provide more precise access to the wall separating the left and right sides of the heart. Robert Harrison, Baylis's director of research and development for cardiology, said in addition to locating the precise puncture point for mitral valve reconstruction, the Versacross transseptal solution has reduced the number of devices exchanged during the procedure to an all-in-one platform.

TORONTO – A Halifax, Nova Scotia-based med-tech company has patented a device that removes CO? from anesthetic equipment in the OR in a way that is safer, more long-lasting and environmentally friendlier than conventional chemical absorbers. The Memsorb is the brain child of anesthesiologist and Dmf Medical Inc. CMO Michael Schmidt who said anesthetizing patients during a long procedure can produce an amount of CO2 equivalent to 7,500 kilometers of travel in a car.